L
Ling Li
Researcher at China Medical University (PRC)
Publications - 16
Citations - 706
Ling Li is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 8, co-authored 13 publications receiving 377 citations. Previous affiliations of Ling Li include Tianjin Medical University.
Papers
More filters
Journal ArticleDOI
Standards of medical care for type 2 diabetes in China 2019.
Weiping Jia,Jianping Weng,Dalong Zhu,Linong Ji,Juming Lu,Zhiguang Zhou,Dajin Zou,Lixin Guo,Qiuhe Ji,Li Chen,Liming Chen,Jingtao Dou,Xiaohui Guo,Hongyu Kuang,Ling Li,Qifu Li,Xiaoying Li,Jing Liu,Xingwu Ran,Lixin Shi,Guangyao Song,Xinhua Xiao,Liyong Yang,Zhigang Zhao +23 more
TL;DR: The main contents include epidemiology of type 2 diabetes in China; diagnosis and classification of diabetes; primary, secondary, and tertiary diabetes prevention; diabetes education and management support; blood glucose monitoring; integrated control targets for type 1 diabetes and treatments for hyperglycaemia.
Journal ArticleDOI
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study
Xiaoxu Huo,Leili Gao,Lixin Guo,Wen Xu,Wenbo Wang,Xinyue Zhi,Ling Li,Yanfeng Ren,Xiuying Qi,Zhong Sun,Weidong Li,Qiuhe Ji,Xingwu Ran,Benli Su,Chuanming Hao,Juming Lu,Xiaohui Guo,Hanjing Zhuo,Danyi Zhang,Chang-yu Pan,Jianping Weng,Dayi Hu,Xilin Yang,Linong Ji +23 more
TL;DR: Results of the validation study showed that exclusion of patients with diet only and non-adjustment for lipid-lowering and antihypertensive drugs resulted in marginal changes in ORs for risk of non-fatal cardiovascular disease in patients with early-onset versus late-onet type 2 diabetes.
Journal ArticleDOI
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Dalong Zhu,Shenglian Gan,Yu Liu,Jianhua Ma,Xiaolin Dong,Weihong Song,Jiao'e Zeng,Guixia Wang,Wenjuan Zhao,Qiu Zhang,Yukun Li,Hui Fang,Xiaofeng Lv,Yongquan Shi,Haoming Tian,Linong Ji,Xin Gao,Lihui Zhang,Yuqian Bao,Minxiang Lei,Ling Li,Longyi Zeng,Xiaoying Li,Xinghua Hou,Yu Zhao,Tianxin Hu,Xiaoyun Ge,Guiyu Zhao,Yongguo Li,Yi Zhang,Li Chen +30 more
TL;DR: Dorzagliatin had a beneficial effect on glycaemic control and was safe and well tolerated over 12 weeks in Chinese patients with type 2 diabetes.
Journal ArticleDOI
Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetes
Ling Li,Linong Ji,Xiaohui Guo,Qiuhe Ji,Weijun Gu,Xinyue Zhi,Xing Li,Hongyu Kuang,Benli Su,Jinhua Yan,Xilin Yang +10 more
TL;DR: Chinese patients with early-onset T2DM are at a marked increased risk of microvascular diseases, especially among patients from 45 to 59years of age.
Journal ArticleDOI
An Age-Specific Serum Thyrotropin Reference Range for the Diagnosis of Thyroid Diseases in Older Adults: A Cross-Sectional Survey in China.
Xiaodan Zhai,Le Zhang,Lulu Chen,Xiaolan Lian,Chao Liu,Bingyin Shi,Lixin Shi,Nanwei Tong,Shu Wang,Jianping Weng,Jiajun Zhao,Xiaochun Teng,Xiaohui Yu,Yaxin Lai,Weiwei Wang,Chenyan Li,Jinyuan Mao,Yongze Li,Chenling Fan,Ling Li,Zhongyan Shan,Weiping Teng +21 more
TL;DR: The serum TSH level increases with age, which may represent a normal compensatory phenomenon in older adults ≥65 years, and the use of an age-specific serum T SH reference range is recommended in Older adults for the diagnosis of thyroid diseases.